Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of afamelanotide in patients with Xeroderma Pigmentosum is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xeroderma Pigmentosum

Drugs mentioned

• Afamelanotide (afamelanotide)

Snippet

Sponsor: Clinuvel Europe Limited | Conditions: Xeroderma Pigmentosum | Phase 2 | Status: UNKNOWN